Literature DB >> 15293134

Epidemiological and clinical study of sporadic acute hepatitis E caused by indigenous strains of hepatitis E virus in Japan compared with acute hepatitis A.

Shigehiko Sainokami1, Koichi Abe, Ichiro Kumagai, Akio Miyasaka, Ryujin Endo, Yasuhiro Takikawa, Kazuyuki Suzuki, Hitoshi Mizuo, Yoshiki Sugai, Yoshihiro Akahane, Yoichi Koizumi, Yoshiaki Yajima, Hiroaki Okamoto.   

Abstract

BACKGROUND: We compared acute hepatitis E (AH-E) and acute hepatitis A (AH-A) to investigate the epidemiology, clinical features, and prognosis of AH-E caused by an indigenous hepatitis E virus (HEV) in Japan.
METHODS: We enrolled 58 patients diagnosed with AH-A or AH-E (32 men and 26 women; age, 20-72 years) from December 1997 to October 2002. Phylogenetic analysis of the partial 412-nucleotide sequence of open reading frame (ORF) 2 was performed in patients with AH-E.
RESULTS: Regarding the geographic distribution of the HEV genotype, genotype III was principally distributed in Honshu Island, and genotype IV in Hokkaido Island ( P = 0.0034). The phylogenetic analysis of the ORF2 region revealed that there were significant geographic differences in the distribution of the HEV strains in Japan, with some strains being widespread and some, localized. In comparison with AH-A patients, those with AH-E were older (56.1 +/- 10.6 vs 45.9 +/- 10.8 years; P = 0.0017). The proportion of males among patients with AH-E was significantly higher ( P = 0.0001). Pyrexia was often observed in AH-A, and malaise in AH-E. Laboratory data indicate that AH-E induces a weak immunological reaction, whereas jaundice appears earlier in AH-E than in AH-A. One patient with AH-E died of acute hepatic failure, but none of those with AH-A died during the study period.
CONCLUSIONS: Our results suggest that there are geographical differences between HEV strains in Japan, and that AH-E is more common in males and older patients than AH-A. Laboratory data indicate a weak immunological reaction and early appearance of jaundice in AH-E.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15293134     DOI: 10.1007/s00535-003-1359-5

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  11 in total

1.  Serological and molecular study of hepatitis E virus among illegal blood donors.

Authors:  Xian-Feng Cheng; Yu-Feng Wen; Ming Zhu; Sheng-Wei Zhan; Jin-Xiu Zheng; Chen Dong; Ke-Xia Xiang; Xiao-Bing Xia; Gang Wang; Ling-Fei Han
Journal:  World J Gastroenterol       Date:  2012-03-07       Impact factor: 5.742

2.  Risk factors and immune response to hepatitis E viral infection among acute hepatitis patients in Assiut, Egypt.

Authors:  Salwa S Seif Eldin; Ismail Seddik; Enas A Daef; M T Shata; Marwa Raafat; Laila Abdel Baky; M A Nafeh
Journal:  Egypt J Immunol       Date:  2010

Review 3.  Hepatitis E virus and neurological injury.

Authors:  Harry R Dalton; Nassim Kamar; Jeroen J J van Eijk; Brendan N Mclean; Pascal Cintas; Richard P Bendall; Bart C Jacobs
Journal:  Nat Rev Neurol       Date:  2015-12-29       Impact factor: 42.937

4.  Asymptomatic acute hepatitis E in a female patient with ulcerative colitis.

Authors:  Kazuyuki Suzuki; Ichiro Kumagai; Yuichi Yoshida; Akio Miyasaka; Yasuhiro Takikawa; Ryoichi Kamiya; Kouryo Kondo; Akinobu Kato; Toshimi Chiba; Hiroaki Okamoto
Journal:  Clin J Gastroenterol       Date:  2017-03-28

5.  Comparison of effects of hepatitis E or A viral superinfection in patients with chronic hepatitis B.

Authors:  Xiaohong Zhang; Weimin Ke; Junqiang Xie; Zhixin Zhao; Dongying Xie; Zhiliang Gao
Journal:  Hepatol Int       Date:  2010-08-01       Impact factor: 6.047

Review 6.  Autochthonous hepatitis e virus infections: a new transfusion-associated risk?

Authors:  Jens Dreier; David Juhl
Journal:  Transfus Med Hemother       Date:  2013-12-30       Impact factor: 3.747

7.  Sporadic acute hepatitis E occurred constantly during the last decade in northeast Japan.

Authors:  Jun Inoue; Yoshiyuki Ueno; Futoshi Nagasaki; Takehiro Akahane; Koji Fukushima; Takayuki Kogure; Yasuteru Kondo; Eiji Kakazu; Keiichi Tamai; Osamu Kido; Yu Nakagome; Masashi Ninomiya; Noriyuki Obara; Yuta Wakui; Masaharu Takahashi; Hiroaki Okamoto; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2009-03-07       Impact factor: 7.527

8.  Pathobiology of hepatitis E: lessons learned from primate models.

Authors:  Robert H Purcell; Ronald E Engle; Sugantha Govindarajan; Richard Herbert; Marisa St Claire; William R Elkins; Anthony Cook; Charlene Shaver; Michelle Beauregard; Joanne Swerczek; Suzanne U Emerson
Journal:  Emerg Microbes Infect       Date:  2013-03-13       Impact factor: 7.163

9.  Hepatitis E: a complex and global disease.

Authors:  E Pelosi; I Clarke
Journal:  Emerg Health Threats J       Date:  2008-11-07

10.  The development of a combined mathematical model to forecast the incidence of hepatitis E in Shanghai, China.

Authors:  Hong Ren; Jian Li; Zheng-An Yuan; Jia-Yu Hu; Yan Yu; Yi-Han Lu
Journal:  BMC Infect Dis       Date:  2013-09-08       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.